CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 214 filers reported holding CYTOKINETICS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $677,000 | -24.8% | 14,769 | -20.5% | 0.00% | -25.0% |
| Q3 2022 | $900,000 | +23.3% | 18,579 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $730,000 | -47.3% | 18,579 | -50.6% | 0.00% | -40.0% |
| Q1 2022 | $1,385,000 | -54.4% | 37,630 | -43.5% | 0.01% | -50.0% |
| Q4 2021 | $3,037,000 | +27.6% | 66,629 | 0.0% | 0.01% | +25.0% |
| Q3 2021 | $2,381,000 | +80.5% | 66,629 | 0.0% | 0.01% | +60.0% |
| Q2 2021 | $1,319,000 | -14.9% | 66,629 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $1,550,000 | +11.9% | 66,629 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $1,385,000 | -20.9% | 66,629 | -17.6% | 0.01% | -40.0% |
| Q3 2020 | $1,750,000 | -8.1% | 80,829 | 0.0% | 0.01% | -9.1% |
| Q2 2020 | $1,905,000 | +70.7% | 80,829 | -14.6% | 0.01% | +37.5% |
| Q1 2020 | $1,116,000 | +25.4% | 94,644 | +12.8% | 0.01% | +60.0% |
| Q4 2019 | $890,000 | +2.9% | 83,892 | +10.4% | 0.01% | 0.0% |
| Q3 2019 | $865,000 | -22.6% | 75,995 | -23.5% | 0.01% | -16.7% |
| Q2 2019 | $1,117,000 | +26.8% | 99,325 | -8.8% | 0.01% | +20.0% |
| Q1 2019 | $881,000 | +67.2% | 108,875 | +30.6% | 0.01% | +66.7% |
| Q4 2018 | $527,000 | -13.9% | 83,387 | +34.2% | 0.00% | 0.0% |
| Q3 2018 | $612,000 | +0.3% | 62,119 | -15.5% | 0.00% | 0.0% |
| Q2 2018 | $610,000 | +15.3% | 73,529 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $529,000 | -19.4% | 73,529 | -8.6% | 0.00% | 0.0% |
| Q4 2017 | $656,000 | +73.1% | 80,480 | +207.8% | 0.00% | +50.0% |
| Q3 2017 | $379,000 | -69.3% | 26,147 | -74.4% | 0.00% | -33.3% |
| Q2 2017 | $1,236,000 | +88.4% | 102,132 | +100.0% | 0.00% | -25.0% |
| Q1 2017 | $656,000 | +21.7% | 51,066 | 0.0% | 0.00% | +33.3% |
| Q4 2016 | $539,000 | +14.9% | 51,066 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $469,000 | -3.3% | 51,066 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $485,000 | +267.4% | 51,066 | +173.0% | 0.00% | +200.0% |
| Q1 2016 | $132,000 | -32.7% | 18,706 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $196,000 | +300.0% | 18,706 | +154.9% | 0.00% | – |
| Q3 2015 | $49,000 | – | 7,338 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,989,218 | $47,348,000 | 10.09% |
| EcoR1 Capital, LLC | 2,139,697 | $20,306,000 | 8.01% |
| Healthcare Value Capital, LLC | 100,000 | $949,000 | 1.15% |
| DAFNA Capital Management LLC | 150,000 | $1,424,000 | 1.13% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 151,106 | $1,434,000 | 1.07% |
| Avoro Capital Advisors LLC | 503,900 | $4,782,000 | 1.06% |
| ACUTA CAPITAL PARTNERS, LLC | 140,969 | $1,338,000 | 0.64% |
| Iguana Healthcare Management, LLC | 150,000 | $1,424,000 | 0.58% |
| WASATCH ADVISORS LP | 1,746,096 | $16,570,000 | 0.25% |
| Virtus ETF Advisers LLC | 29,379 | $279,000 | 0.21% |